Journal
AGING-US
Volume 13, Issue 1, Pages 1510-1527Publisher
IMPACT JOURNALS LLC
Keywords
glioma; aging; bioenergetics
Categories
Funding
- NIH [T32MH079785]
Ask authors/readers for more resources
Despite the increasing risk of brain cancer in the elderly population, treatment prognosis remains poor due to limited understanding of underlying mechanisms and treatment options. Dysregulation of metabolism and signaling pathways in glial cells during aging may promote tumor progression through interactions with oncogenic processes. Despite limitations, studying aberrant PIK3/AKT/mTOR signaling in glial cells during aging unveils therapeutic opportunities for brain tumor treatment.
Despite a growing proportion of aged individuals at risk for developing cancer in the brain, the prognosis for these conditions remains abnormally poor due to limited knowledge of underlying mechanisms and minimal treatment options. While cancer metabolism in other organs is commonly associated with upregulated glycolysis (i.e. Warburg effect) and hyperactivation of PIK3/AKT/mTOR (PAM) pathways, the unique bioenergetic demands of the central nervous system may interact with these oncogenic processes to promote tumor progression in aging. Specifically, constitutive glycolysis and PIK3/AKT/mTOR signaling in glia may be dysregulated by age-dependent alterations in neurometabolic demands, ultimately contributing to pathological processes otherwise associated with PIK3/AKT/mTOR induction (e.g. cell cycle entry, impaired autophagy, dysregulated inflammation). Although several limitations to this theoretical model exist, the consideration of aberrant PIK3/AKT/mTOR signaling in glia during aging elucidates several therapeutic opportunities for brain tumors, including non-pharmacological interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available